Loading...
Loading...
.webp&w=1536&q=75)
CDSCO is responsible for approving drugs and clinical trials, setting standards for drugs, ensuring the quality of imported drugs, and coordinating with State Drug Control Organizations to enforce the Drugs and Cosmetics Act and relevant rules.
About the Author
Yash Chauhan is a law graduate from the University of Delhi and a skilled content writer at Corpseed. With a keen interest in the legal industry, he specializes in writing articles on contemporary legal developments, corporate compliances, business regulations, environmental circulars, and licensing procedures. His well-researched and insightful content provides valuable information to businesses and individuals navigating the legal landscape.
Related articles
CDSCO Mandates ONDLS Portal for r-DNA Drug License Applications
2026-03-16
New Drug Manufacturing and Clinical Trial Rules Updated in 2026: What You Should Know?
2026-03-13
CDSCO Releases New Guidelines for Compounding of Offences Under the Drugs and Cosmetics Act
2026-02-26
Regulation of Medical Device Pricing and Quality in India: Key Government Measures
2026-02-20
CDSCO Releases Risk Classification List for Oncology Medical Devices
2026-02-12
Government Notifies CGHS Drug Procurement Policy 2026
2026-01-24
2026-04-07 • 0 views
2023-02-27
2026-04-08
.png&w=1536&q=75)
